UCSF

2021 News

two blue plates with tubes
The Kidney Project earned a $650,000 award for a successful demonstration of its artificial kidney
Image of bacterial cells
A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.
Guglielmo
School leadership changes, our ongoing fight against COVID-19, and the latest accomplishments of students, faculty members, and staff members
Helium recycling equipment
The School is now recycling much of the helium used in its NMR facilities.
Illustration of chromosomes and double helix of DNA
Research on Neanderthal DNA reveals new details about our evolutionary cousins
laboratory with scientist reading container label
Faculty members have until May 14 to apply for “risky and innovative research” funding from the Chan Zuckerberg Biohub.
Student inspecting a patient's medication bottle
A task force brainstorms new ways to make the PharmD curriculum anti-racist, equitable, and inclusive
Koda-Kimble
The Mary Anne Koda-Kimble Seed Award for Innovation will fuel eight bold research projects across the School this year
Guglielmo
All the latest on COVID-19 vaccinations, a careful return to in-person education, science, and more.
Oni-Orisan
Burchard and Oni-Orisan contribute to two opinion pieces grappling with issues of race and inequity in medicine
Hernandez
Collaborative effort ensures precision medicine will be based on the genetics of a diverse pool of people
Day
The School community celebrated the establishment of the Bob Day Student Center and the Bob Day Student Support Fund.
two scientists in laboratory
A one-year Fellowship within HIVE seeks to inspire and encourage bioengineers to address grand challenges of health care.
Burchard
Over $40 million in 2020 NIH funding to the School supported research ranging from the genomics of asthma to new malaria treatments
Aludino and employee record dose of vaccine
Pharmacy students, technicians, faculty members, and providers all pitched in to the rollout of the COVID-19 vaccine.
DNA double helix
Advance opens up new possibilities for CAR T-cell therapy to treat a variety of cancers